Medicare lanza piloto Wegovy de $50 con criterios estrictos

Medicare lanza piloto Wegovy de $50 con criterios estrictos

Salud

Los Centros de Medicare y Medicaid anunciaron que el 1 de julio de 2026 Medicare puso en marcha un programa piloto de Wegovy con un copago mensual de $50, disponible solo para los beneficiarios que cumplen estrictos criterios de índice de masa corporal, condiciones de salud y que están inscritos en un plan Part D. Se trata de una demostración de 18 meses que cubre medicamentos GLP-1 para la obesidad, incluido Wegovy, a cambio de un copago de $50 al mes. Según informes de CBS News, CNBC, ABC News y AP News, la elegibilidad está restringida a adultos mayores que superen umbrales de IMC y presenten determinadas afecciones, y el programa está previsto que finalice a finales de 2027.

Actores

Medicare Centers for Medicare & Medicaid Services Eli Lilly Novo Nordisk Juliette Cubanski KFF

Ubicaciones

Sin registros

Artículos

29 de julio de 2026
1 en total
As of July 1, Medicare Covers Wegovy for Weight Loss at $50 a Month. The Eligibility List Is Short.
As of July 1, Medicare Covers Wegovy for Weight Loss at $50 a Month. The Eligibility List Is Short.

24/7 Wall St. • 29 de jul 12:03

Starting July 1, 2026, Medicare will offer a $50 copay for certain GLP-1 drugs, including Wegovy, but only beneficiaries who meet specific BMI and health-condition requirements and are enrolled in an eligible Part D plan can access the benefit.

Credibilidad 72% Manip. 8% Centro
1 de julio de 2026
2 en total
What to know about Medicare's $50 GLP-1 program
What to know about Medicare's $50 GLP-1 program

AP News • 1 de jul 11:09

A new Medicare program will provide selected GLP-1 weight-loss medications to qualifying beneficiaries for $50 a month through 2027, with eligibility based on BMI and health conditions.

Credibilidad 78% Manip. 8% Centro
Eligible seniors can get GLP-1s for $50 a month for weight loss alone
Eligible seniors can get GLP-1s for $50 a month for weight loss alone

ABC News - Breaking News, Latest News and Videos • 1 de jul 09:14

A new federal pilot program will allow eligible Medicare beneficiaries to obtain GLP-1 medications for obesity at a $50 co-pay per month, beginning in July and running through the end of 2027.

Credibilidad 72% Manip. 8% Centro
30 de junio de 2026
1 en total
Medicare obesity drug GLP-1 coverage starting July 1
Medicare obesity drug GLP-1 coverage starting July 1

CNBC • 30 de jun 09:00

A new Medicare demonstration program will pay for GLP-1 obesity medications for eligible seniors at a $50 monthly copayment, but the coverage is set to expire in 2027.

Credibilidad 78% Manip. 9% Centro
29 de junio de 2026
1 en total
Medicare to cover GLP-1 drugs for weight loss starting July 1. Here's what to know.
Medicare to cover GLP-1 drugs for weight loss starting July 1. Here's what to know.

CBS News • 29 de jun 19:39

Starting July 1, Medicare will offer an 18-month pilot that pays for certain GLP-1 medications prescribed for obesity, requiring a $50 monthly copay for eligible beneficiaries.

Credibilidad 73% Manip. 12% Centro

Eventos relacionados